or Try an Advanced Search...

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    D 118.75 -2.01% -2.43
    MRNA closed down 2.01 percent on Friday, June 28, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    56 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Multiple of Ten Bearish Other 0.00%
    Outside Day Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish -2.01%
    Multiple of Ten Bullish Other -2.01%
    Below Lower BB Weakness -2.01%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts

    Alert Time
    Outside Day 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Down 2 % 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MRNA Chart by TradingView
    Basic chart:

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Nasdaq 100 Biology Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 CDC Narrows Age Recommendation for Use of RSV Vaccine
    Jun 28 Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
    Jun 28 Carisma jumps as drug discovery under Moderna deal leads to $2M payment
    Jun 28 Moderna RSV vaccine endorsed in EU
    Jun 28 EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
    Jun 27 Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
    Jun 27 RSV vaccine makers’ shares fall as CDC adjusts shot guidance
    Jun 27 CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
    Jun 27 2 Stocks Down More Than 30% to Buy Right Now
    Jun 26 How consumer spending, election impact markets: Market Domination
    See more MRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 170.47
    52 Week Low 62.65
    Average Volume 4,124,157
    200-Day Moving Average 103.85
    50-Day Moving Average 132.20
    20-Day Moving Average 140.11
    10-Day Moving Average 131.60
    Average True Range 7.08
    RSI (14) 32.89
    ADX 24.96
    +DI 16.51
    -DI 34.31
    Chandelier Exit (Long, 3 ATRs) 137.59
    Chandelier Exit (Short, 3 ATRs) 139.26
    Upper Bollinger Bands 160.78
    Lower Bollinger Band 119.43
    Percent B (%b) -0.02
    BandWidth 29.51
    MACD Line -3.52
    MACD Signal Line 0.14
    MACD Histogram -3.6522
    Fundamentals Value
    Market Cap 45.28 Billion
    Num Shares 381 Million
    EPS -9.23
    Price-to-Earnings (P/E) Ratio -12.87
    Price-to-Sales 3.91
    Price-to-Book 2.48
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 126.58
    Resistance 3 (R3) 127.21 125.23 125.27
    Resistance 2 (R2) 125.23 123.24 124.91 124.84
    Resistance 1 (R1) 121.99 122.00 121.00 121.36 124.40
    Pivot Point 120.01 120.01 119.51 119.69 120.01
    Support 1 (S1) 116.77 118.02 115.78 116.14 113.10
    Support 2 (S2) 114.79 116.78 114.48 112.66
    Support 3 (S3) 111.55 114.79 112.23
    Support 4 (S4) 110.92